Cargando…

Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU

INTRODUCTION: Hepatic dysfunction is a common finding in critically ill patients on the ICU and directly influences survival. Liver stiffness can be measured by the novel method of transient elastography (fibroscan) and is closely associated with hepatic fibrosis in patients with chronic liver disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Koch, Alexander, Horn, Andreas, Dückers, Hanna, Yagmur, Eray, Sanson, Edouard, Bruensing, Jan, Buendgens, Lukas, Voigt, Sebastian, Trautwein, Christian, Tacke, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388655/
https://www.ncbi.nlm.nih.gov/pubmed/22082207
http://dx.doi.org/10.1186/cc10543
_version_ 1782237219915825152
author Koch, Alexander
Horn, Andreas
Dückers, Hanna
Yagmur, Eray
Sanson, Edouard
Bruensing, Jan
Buendgens, Lukas
Voigt, Sebastian
Trautwein, Christian
Tacke, Frank
author_facet Koch, Alexander
Horn, Andreas
Dückers, Hanna
Yagmur, Eray
Sanson, Edouard
Bruensing, Jan
Buendgens, Lukas
Voigt, Sebastian
Trautwein, Christian
Tacke, Frank
author_sort Koch, Alexander
collection PubMed
description INTRODUCTION: Hepatic dysfunction is a common finding in critically ill patients on the ICU and directly influences survival. Liver stiffness can be measured by the novel method of transient elastography (fibroscan) and is closely associated with hepatic fibrosis in patients with chronic liver disease, but also is increased in patients with acute hepatitis, acute liver failure and cholestasis. We investigated liver stiffness as a potentially useful tool for early detection of patients with hepatic deterioration and risk stratification with respect to short- and long-term mortality. METHODS: We prospectively evaluated 108 consecutive critically ill patients at our medical intensive care unit (ICU) with subsequent longitudinal liver stiffness measurements (admission, Day 3, Day 7 and weekly thereafter) during the course of ICU treatment. Outcome was followed after discharge (median observation time 237 days). RESULTS: Liver stiffness could be reliably measured in 71% of ICU patients at admission (65% at Day 3, 63% at Day 7). Critically ill patients (n = 108) had significantly increased liver stiffness compared to sex- and age-matched standard care patients (n = 25). ICU patients with decompensated cirrhosis showed highest liver stiffness, whereas other critical diseases (for example, sepsis) and comorbidities (for example, diabetes, obesity) did not impact stiffness values. At admission to the ICU, liver stiffness is closely related to hepatic damage (liver synthesis, cholestasis, fibrosis markers). During the course of ICU treatment, fluid overload (renal failure, volume therapy) and increased central venous pressure (mechanical ventilation, heart failure) were major factors determining liver stiffness. Liver stiffness values > 18 kilopascal (kPa) at ICU admission were associated with increased ICU and long-term mortality, even in non-cirrhotic patients. CONCLUSIONS: Considering that liver stiffness cannot be validly measured in about 30% of ICU patients, transient elastography performed at ICU admission might be a useful tool to early identify liver dysfunction and predict mortality in critically ill patients at a medical ICU.
format Online
Article
Text
id pubmed-3388655
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33886552012-07-04 Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU Koch, Alexander Horn, Andreas Dückers, Hanna Yagmur, Eray Sanson, Edouard Bruensing, Jan Buendgens, Lukas Voigt, Sebastian Trautwein, Christian Tacke, Frank Crit Care Research INTRODUCTION: Hepatic dysfunction is a common finding in critically ill patients on the ICU and directly influences survival. Liver stiffness can be measured by the novel method of transient elastography (fibroscan) and is closely associated with hepatic fibrosis in patients with chronic liver disease, but also is increased in patients with acute hepatitis, acute liver failure and cholestasis. We investigated liver stiffness as a potentially useful tool for early detection of patients with hepatic deterioration and risk stratification with respect to short- and long-term mortality. METHODS: We prospectively evaluated 108 consecutive critically ill patients at our medical intensive care unit (ICU) with subsequent longitudinal liver stiffness measurements (admission, Day 3, Day 7 and weekly thereafter) during the course of ICU treatment. Outcome was followed after discharge (median observation time 237 days). RESULTS: Liver stiffness could be reliably measured in 71% of ICU patients at admission (65% at Day 3, 63% at Day 7). Critically ill patients (n = 108) had significantly increased liver stiffness compared to sex- and age-matched standard care patients (n = 25). ICU patients with decompensated cirrhosis showed highest liver stiffness, whereas other critical diseases (for example, sepsis) and comorbidities (for example, diabetes, obesity) did not impact stiffness values. At admission to the ICU, liver stiffness is closely related to hepatic damage (liver synthesis, cholestasis, fibrosis markers). During the course of ICU treatment, fluid overload (renal failure, volume therapy) and increased central venous pressure (mechanical ventilation, heart failure) were major factors determining liver stiffness. Liver stiffness values > 18 kilopascal (kPa) at ICU admission were associated with increased ICU and long-term mortality, even in non-cirrhotic patients. CONCLUSIONS: Considering that liver stiffness cannot be validly measured in about 30% of ICU patients, transient elastography performed at ICU admission might be a useful tool to early identify liver dysfunction and predict mortality in critically ill patients at a medical ICU. BioMed Central 2011 2011-11-14 /pmc/articles/PMC3388655/ /pubmed/22082207 http://dx.doi.org/10.1186/cc10543 Text en Copyright ©2011 Koch et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Koch, Alexander
Horn, Andreas
Dückers, Hanna
Yagmur, Eray
Sanson, Edouard
Bruensing, Jan
Buendgens, Lukas
Voigt, Sebastian
Trautwein, Christian
Tacke, Frank
Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU
title Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU
title_full Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU
title_fullStr Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU
title_full_unstemmed Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU
title_short Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU
title_sort increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical icu
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388655/
https://www.ncbi.nlm.nih.gov/pubmed/22082207
http://dx.doi.org/10.1186/cc10543
work_keys_str_mv AT kochalexander increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu
AT hornandreas increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu
AT duckershanna increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu
AT yagmureray increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu
AT sansonedouard increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu
AT bruensingjan increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu
AT buendgenslukas increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu
AT voigtsebastian increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu
AT trautweinchristian increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu
AT tackefrank increasedliverstiffnessdenoteshepaticdysfunctionandmortalityriskincriticallyillnoncirrhoticpatientsatamedicalicu